These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21495800)

  • 41. Relationship between the oestradiol/oocyte ratio and the outcome of assisted reproductive technology cycles with gonadotropin releasing hormone agonist.
    Var T; Tonguc E; Dogan M; Mollamahmutoglu L
    Gynecol Endocrinol; 2011 Aug; 27(8):558-61. PubMed ID: 20642381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Application of GnRH-antagonist to IVF-ET for patients with poor ovarian response].
    Wang B; Sun HX; Hu YL; Chen H; Zhang NY
    Zhonghua Nan Ke Xue; 2008 May; 14(5):423-6. PubMed ID: 18572861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scheduling GnRH antagonist cycles by a short course of oral estradiol administration during early follicular phase: a comparative study with non-scheduled cycles.
    Aslan K; Avci B; Uncu G; Saribal S; Ata B
    Gynecol Endocrinol; 2015 Jun; 31(6):465-8. PubMed ID: 25982362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro fertilization for Orthodox Jewish couples: antagonist cycle modifications allowing for mikveh attendance before oocyte retrieval.
    Reichman DE; Brauer AA; Goldschlag D; Schattman G; Rosenwaks Z
    Fertil Steril; 2013 Apr; 99(5):1408-12. PubMed ID: 23312229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the Second Follicular Wave Phenomenon in Natural Cycle Assisted Reproduction: A Key Option for Poor Responders through Luteal Phase Oocyte Retrieval.
    Sfakianoudis K; Simopoulou M; Maziotis E; Giannelou P; Tsioulou P; Rapani A; Pantou A; Petroutsou K; Angeli I; Deligeoroglou E; Koutsilieris M; Pantos K
    Medicina (Kaunas); 2019 Mar; 55(3):. PubMed ID: 30875815
    [No Abstract]   [Full Text] [Related]  

  • 46. Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study.
    Wang N; Wang Y; Chen Q; Dong J; Tian H; Fu Y; Ai A; Lyu Q; Kuang Y
    Clin Endocrinol (Oxf); 2016 May; 84(5):720-8. PubMed ID: 26603821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of luteal estradiol pre-treatment on the outcome of IVF in poor ovarian responders.
    Chang X; Wu J
    Gynecol Endocrinol; 2013 Mar; 29(3):196-200. PubMed ID: 23194136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders.
    Fàbregues F; Solernou R; Ferreri J; Guimerá M; Peralta S; Casals G; Peñarrubia J; Creus M; Manau D
    JBRA Assist Reprod; 2019 Apr; 23(2):130-136. PubMed ID: 30614665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IVF Outcomes of Microdose Flare-up, GnRH Antagonist, and Long Protocols in Patients having a Poor Ovarian Response in the First Treatment Cycle.
    Demirdağ E; Akdulum MFC; Guler I; Oguz Y; Erdem A; Erdem M
    J Coll Physicians Surg Pak; 2021 May; 31(5):523-527. PubMed ID: 34027862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing the practice of LuPOR for poor responders: a prospective study evaluating follicular fluid cfDNA levels during natural IVF cycles.
    Sfakianoudis K; Tsioulou P; Maziotis E; Giannelou P; Glava A; Grigoriadis S; Rapani A; Nezos A; Pantou A; Koutsilieris M; Pantos K; Mastorakos G; Simopoulou M
    J Assist Reprod Genet; 2020 May; 37(5):1183-1194. PubMed ID: 32221790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Luteal phase ovarian stimulation for poor ovarian responders.
    Zhang W; Wang M; Wang S; Bao H; Qu Q; Zhang N; Hao C
    JBRA Assist Reprod; 2018 Sep; 22(3):193-198. PubMed ID: 29931967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Luteal phase ovarian stimulation following oocyte retrieval: is it helpful for poor responders?
    Zhang J
    Reprod Biol Endocrinol; 2015 Jul; 13():76. PubMed ID: 26209449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A luteal estradiol protocol for expected poor-responders improves embryo number and quality.
    Frattarelli JL; Hill MJ; McWilliams GDE; Miller KA; Bergh PA; Scott RT
    Fertil Steril; 2008 May; 89(5):1118-1122. PubMed ID: 17658529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Random-start ovarian stimulation in patients with cancer.
    Cakmak H; Rosen MP
    Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do follicular fluid gelatinase levels affect fertilization rates and oocyte quality?
    Bilen E; Tola EN; Oral B; Doguç DK; Günyeli I; Köse SA; Ilhan I
    Arch Gynecol Obstet; 2014 Dec; 290(6):1265-71. PubMed ID: 25027821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ovarian stimulation in the luteal phase: systematic review and meta-analysis.
    Boots CE; Meister M; Cooper AR; Hardi A; Jungheim ES
    J Assist Reprod Genet; 2016 Aug; 33(8):971-80. PubMed ID: 27146151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estradiol use in the luteal phase and its effects on pregnancy rates in IVF cycles with GnRH antagonist: a systematic review.
    Pinheiro LMA; Cândido PDS; Moreto TC; Almeida WGD; Castro EC
    JBRA Assist Reprod; 2017 Sep; 21(3):247-250. PubMed ID: 28837035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences.
    Fauser BC; Devroey P
    Trends Endocrinol Metab; 2003 Jul; 14(5):236-42. PubMed ID: 12826330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors and implications of estradiol rise after gonadotropin-releasing hormone antagonist initiation during in vitro fertilization cycles.
    Scotchie JG; Will M; Fritz MA; Steiner AZ
    J Reprod Med; 2009 Apr; 54(4):211-7. PubMed ID: 19438162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial.
    Llácer J; Moliner B; Luque L; Bernabéu A; Lledó B; Castillo JC; Guerrero J; Ten J; Bernabéu R
    Reprod Biol Endocrinol; 2020 Feb; 18(1):9. PubMed ID: 32033610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.